Related by context. Frequent words. (Click for all words.) 63 Phase Ib clinical 60 novel anticancer 60 pertuzumab 59 ARC# [001] 59 liposomal formulation 57 phase IIa 57 multiple myeloma MM 57 KRN# 57 Phase 2a trial 56 relapsing multiple sclerosis 55 AACR NCI EORTC 55 relapsed refractory 55 pharmacokinetic PK 55 Abstract Number 54 radiolabeled 54 Phase 1b trial 54 EORTC 54 angiogenesis inhibitor 54 MEK inhibitor 54 tyrosine kinase inhibitor 54 mTOR inhibitor 54 axitinib 54 Traficet EN 53 bleomycin 53 EZN 53 intravesical 53 immune modulation 53 Carfilzomib 53 adenoviral 53 eniluracil 53 CCX# 53 Bortezomib 53 Amrubicin 53 anticancer compound 53 Gastrointestinal Cancers Symposium 53 mRCC 53 MORAb 53 therapeutically relevant 52 BAL# [001] 52 PEG SN# 52 TG# [001] 52 potent inhibitor 52 Irinotecan 52 IIa trial 52 Phase III Clinical Trial 52 Phase IIb trials 52 administered subcutaneously 52 etoposide 52 Guanilib 52 Sym# 52 gastrointestinal stromal tumors GIST 52 Preclinical Data 52 bevacizumab Avastin 52 EndoTAG TM -1 51 Dasatinib 51 SABCS 51 tocilizumab 51 INGN 51 Pivotal Trial 51 Trastuzumab 51 HER2 positive metastatic breast 51 heavily pretreated patients 50 Epratuzumab 50 talabostat 50 Erlotinib 50 AVAX 50 TASQ 50 metastatic castration resistant 50 ASH Annual Meeting 50 decitabine 50 XL# [003] 50 Pharmacological 50 BAY #-# 50 biologic therapy 50 vorinostat 50 metastatic renal cell carcinoma 50 anti fibrotic 49 proteasome inhibitors 49 Mipomersen 49 Monoclonal Antibody 49 Oritavancin 49 anti VEGF 49 humanized antibody 49 Antiviral 49 Temozolomide 49 Metastatic Melanoma 49 ocrelizumab 49 colorectal carcinoma 49 xenograft 49 fusion inhibitor 49 Solid Tumors 49 MAb 49 Lenalidomide 49 eculizumab 49 prospective multicenter 49 BMS # 49 nab paclitaxel 48 Natalizumab 48 heavily pretreated 48 Clevudine 48 myeloproliferative disorders